SP100 inhibits ETS1 activity in primary endothelial cells

Oncogene

Volumn 24, Issue 5, 2005, Pages 916-931

  Yordy, John S ^a   Moussa, Omar ^a   Pei, Huiping ^a   Chaussabel, Damien ^b   Li, Runzhao ^a   Watson, Dennis K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

Angiogenesis; ETS1; Microarray; Migration; SP100; Transcription

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANGIOGENESIS INHIBITOR; AUTOANTIGEN; AXIN; AXIN I; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CD14 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; GAMMA AMINOBUTYRIC ACID A RECEPTOR EPSILON; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN A1L; HEAT SHOCK PROTEIN A6; HEAT SHOCK PROTEIN A8; HEAT SHOCK PROTEIN E1; HEAT SHOCK PROTEIN H11; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; PROTEIN; SP100 PROTEIN; STEROID 5ALPHA REDUCTASE; THY 1 ANTIGEN; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN;

ANTIGENS, NUCLEAR; AUTOANTIGENS; BASE SEQUENCE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS; UMBILICAL VEINS;

EID: 13444282063     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208245     Document Type: Article

References (92)

1. Babic AM, Chen CC and Lau LF. (1999). Mol. Cell. Biol., 19, 2958-2966.
2. Baker KM, Wei G, Schaffner AE and Ostrowski MC. (2003). J. Biol. Chem., 278, 17876-17884.
3. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA and Davis GE. (2001). J. Cell Sci., 114, 2755-2773.
4. Brigstock DR. (2002). Angiogenesis, 5, 153-165.
5. Carmeliet P and Jain RK. (2000). Nature, 407, 249-257.
6. Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST, Chau YP, Yang PC and Kuo ML. (2004). J. Natl. Cancer Inst., 96, 364-375.
7. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A and Nutman TB. (2003). Blood, 102, 672-681.
8. Chaussabel D and Sher A. (2002). Genome. Biol., 3, RESEARCH0055.1-0055. 16.
9. Chen Z, Fisher RJ, Riggs CW, Rhim JS and Lautenberger JA. (1997). Cancer Res., 57, 2013-2019.
10. Cui Y, Zhou M and Wong WH. (2004). OMICS, 8, 106-117.
11. Czuwara-Ladykowska J, Sementchenko VI, Watson DK and Trojanowska M. (2002). J. Biol. Chem., 277, 20399-20408.
12. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC and Conklin BR. (2002). Nat. Genet., 31, 19-20.
13. Dandre F and Owens GK. (2004). Am. J. Physiol. Heart Circ. Physiol., 286, H2042-H2051.
14. Davies PA, Hanna MC, Hales TG and Kirkness EF. (1997). Nature, 385, 820-823.
15. Delannoy-Courdent A, Mattot V, Fafeur V, Fauquette W, Pollet I, Calmels T, Vercamer C, Boilly B, Vandenbunder B and Desbiens X. (1998). J. Cell Sci., 111 (Part 11), 1521-1534.
16. Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J and Griffioen AW. (2003). Cancer Res., 63, 2322-2329.
17. Dittmer J. (2003). Mol. Cancer, 2, 29.
18. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC and Conklin BR. (2003). Genome Biol., 4, R7.
19. Edwards AD, Chaussabel D, Tomlinson S, Schulz O, Sher A and Reis e Sousa C. (2003). J. Immunol., 171, 47-60.
20. Entschladen F, Drell TLt, Lang K, Joseph J and Zaenker KS. (2004). Lancet Oncol., 5, 254-258.
21. Folkman J. (1971). N. Engl. J. Med, 285, 1182-1186.
22. Folkman J. (2000) Holland JF (ed). Cancer Medicine. B.C. Decker: Hamilton, Ontario; New York, pp. 132-152.
23. Folkman J and Hanahan D. (1991). Princess Takamatsu Symp., 22, 339-347.
24. Freeman BC and Yamamoto KR. (2002). Science, 296, 2232-2235.
25. Galea E, Santizo R, Feinstein DL, Adamsom P, Greenwood J, Koenig HM and Pelligrino DA. (2002). Neuroreport, 13, 1469-1472.
26. Gerritsen ME, Soriano R, Yang S, Ingle G, Zlot C, Toy K, Winer J, Draksharapu A, Peale F, Wu TD and Williams PM. (2002). Physiol. Genom., 10, 13-20.
27. Goetze S, Kintscher U, Kaneshiro K, Meehan WP, Collins A, Fleck E, Hsueh WA and Law RE. (2001). Atherosclerosis, 159, 93-101.
28. Griffioen AW, Damen CA, Martinotti S, Blijham GH and Groenewegen G. (1996). Cancer Res., 56, 1111-1117.
29. Guldner HH, Szostecki C, Grotzinger T and Will H. (1992). J. Immunol., 149, 4067-4073.
30. Hanai J, Gloy J, Karumanchi SA, Kale S, Tang J, Hu G, Chan B, Ramchandran R, Jha V, Sukhatme VP and Sokol S. (2002). J. Cell Biol., 158, 529-539.
31. Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, Bouchier-Hayes D and Dong Z. (2002). Int. J. Cancer, 101, 415-422.
32. Harris AL. (2002). Nat. Rev. Cancer, 2, 38-47.
33. Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E and Okada Y. (2002). J. Biol. Chem., 277, 36288-36295.
34. Hastings MM, Milot J, Barsoum-Homsy M, Hershon L, Dubois J and Leclerc JM. (1997). J. AAPOS, 1, 226-230.
35. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B. (1998). Proc. Natl. Acad. Sci. USA, 95, 2509-2514.
36. Hsu T, Trojanowska M and Watson DK. (2004). J. Cell. Biochem., 91, 896-903.
37. Igarashi T, Abe M, Oikawa M, Nukiwa T and Sato Y. (2001). Tohoku J. Exp. Med., 194, 35-43.
38. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K and Okada Y. (2002). FASEB J., 16, 219-221.
39. Iwasaka C, Tanaka K, Abe M and Sato Y. (1996). J. Cell. Physiol., 169, 522-531.
40. Jang HS, Kim HJ, Kim JM, Lee YS, Kim KL, Kim JA, Lee JY, Suh W, Choi JH, Jeon ES, Byun J and Kim DK. (2004). Mol. Ther., 9, 464-474.
41. Kawai H, Li H, Chun P, Avraham S and Avraham HK. (2002). Oncogene, 21, 7730-7739.
42. Kevil CG, Orr AW, Langston W, Mickett K, Murphy-Ullrich J, Patel RP, Kucik DF and Bullard DC. (2004). J. Biol. Chem., 279, 19230-19238.
43. Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, Takada R, Takada S and Kikuchi A. (1999). Oncogene, 18, 979-985.
44. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S and Kikuchi A. (1998). J. Biol. Chem., 273, 10823-10826.
45. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J and Sato H. (2001). Cancer Res., 61, 7985-7991.
46. Kumar P, Judson I, Nicholson AG and Ladas G. (2002). J. Thorac. Cardiovasc. Surg., 124, 404-406.
47. Lee E, Salic A, Kruger R, Heinrich R and Kirschner MW. (2003). PLoS Biol., 1, E10.
48. Lee WS, Jain MK, Arkonac BM, Zhang D, Shaw SY, Kashiki S, Maemura K, Lee SL, Hollenberg NK, Lee ME and Haber E. (1998). Circ. Res., 82, 845-851.
49. Lelievre E, Lionneton F, Soncin F and Vandenbunder B. (2001). Int. J. Biochem. Cell. Biol., 33, 391-407.
50. Li R, Pei H and Papas T. (1999). Proc. Natl. Acad. Sci. USA, 96, 3876-3881.
51. Li R, Pei H, Watson DK and Papas TS. (2000). Oncogene, 19, 745-753.
52. Li WW, Grayson G, Folkman J and D'Amore PA. (1991). Invest. Ophthalmol. Vis. Sci., 32, 2906-2911.
53. Lincoln DW, Phillips II PG and Bove K. (2003). Breast Cancer Res. Treat., 78, 167-178.
54. Marler JJ, Rubin JB, Trede NS, Connors S, Grier H, Upton J, Mulliken JB and Folkman J. (2002). Pediatrics, 109, E37.
55. Mattot V, Vercamer C, Soncin F, Calmels T, Huguet C, Fafeur V and Vandenbunder B. (2000). Oncogene, 19, 762-772.
56. Mercurio S, Latinkic B, Itasaki N, Krumlauf R and Smith JC. (2004). Development, 131, 2137-2147.
57. Nakano T, Abe M, Tanaka K, Shineha R, Satomi S and Sato Y. (2000). J. Cell Physiol., 184, 255-262.
58. Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K and Sato Y. (2001). Biochem. Biophys. Res. Commun., 289, 39-43.
59. Oikawa T and Yamada T. (2003). Gene, 303, 11-34.
60. Okubo T, Truong TK, Yu B, Itoh T, Zhao J, Grube B, Zhou D and Chen S. (2001). Cancer Res., 61, 1338-1346.
61. Ortega A. (2003). Trends Pharmacol. Sci., 24, 151-154.
62. Pelicano L, Li F, Schindler C and Chelbi-Alix MK. (1997). Oncogene, 15, 2349-2359.
63. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F and Karsan A. (2003). Blood, 102, 1740-1742.
64. Pourtier-Manzanedo A, Vercamer C, Van Belle E, Mattot V, Mouquet F and Vandenbunder B. (2003). Oncogene, 22, 1795-1806.
65. Ramakers C, Ruijter JM, Deprez RH and Moorman AF. (2003). Neurosci. Lett., 339, 62-66.
66. Raouf A, Li V, Kola I, Watson DK and Seth A. (2000). Oncogene, 19, 1969-1974.
67. Roca C, Primo L, Valdembri D, Cividalli A, Declerck P, Carmeliet P, Gabriele P and Bussolino F. (2003). Cancer Res., 63, 1500-1507.
68. Roy J, Audette M and Tremblay MJ. (2001). J. Biol. Chem., 276, 14553-14561.
69. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V and Quackenbush J. (2003). Biotechniques, 34, 374-378.
70. Sato Y. (2001). Cell. Struct. Funct., 26, 19-24.
71. Schneikert J, Peterziel H, Defossez PA, Klocker H, Launoit Y and Cato AC. (1996). J. Biol. Chem., 271, 23907-23913.
72. Sementchenko VI and Watson DK. (2000). Oncogene, 19, 6533-6548.
73. Semenza GL. (1998). Curr. Opin. Genet. Dev., 8, 588-594.
74. Shimizu S, Kageyama M, Yasuda M, Sasaki D, Naito S, Yamamoto T and Kiuchi Y. (2004). Int. J. Biochem. Cell. Biol., 36, 114-122.
75. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T and Takigawa M. (1999). J. Biochem. (Tokyo), 126, 137-145.
76. St Croix B, Rago C, Velculescu V, Traverse G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW. (2000). Science, 289, 1197-1202.
77. Sturn A, Quackenbush J and Trajanoski Z. (2002). Bioinformatics, 18, 207-208.
78. Thiery JP. (2002). Nat. Rev. Cancer, 2, 442-454.
79. Tolwinski NS and Wieschaus E. (2004). Trends Genet., 20, 177-181.
80. Tomita N, Morishita R, Taniyama Y, Koike H, Aoki M, Shimizu H, Matsumoto K, Nakamura T, Kaneda Y and Ogihara T. (2003). Circulation, 107, 1411-1417.
81. Triantafilou M and Triantafilou K. (2002). Trends Immunol., 23, 301-304.
82. Tryfonas GI, Tsikopoulos G, Liasidou E, Gavopoulos S, Georgakis G, Badouraki M and Soultanides C. (1998). Pediatr. Surg. Int., 13, 590-593.
83. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stehelin D. (1989). Development, 107, 265-274.
84. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I and Nieto MA. (2004). Genes Dev., 18, 1131-1143.
85. von Marschall Z, Scholz A, Cramer T, Schafer G, Schirner M, Oberg K, Wiedenmann B, Hocker M and Rosewicz S. (2003). J. Natl. Cancer Inst., 95, 437-448.
86. Wang L, Wu WZ, Sun HC, Wu XF, Qin LX, Liu YK, Liu KD and Tang ZY. (2003). J. Gastrointest. Surg., 7, 587-594.
87. Watanabe D, Takagi H, Suzuma K, Suzuma I, Oh H, Ohashi H, Kemmochi S, Uemura A, Ojima T, Suganami E, Miyamoto N, Sato Y and Honda Y. (2004). Am. J. Pathol., 164, 1827-1835.
88. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B and Stehelin D. (1992). Am. J. Pathol., 140, 119-127.
89. Wernert N, Stanjek A, Kiriakidis S, Hugel A, Jha HC, Mazitschek R and Giannis A. (1999). Angew. Chem. Int. Ed. Engl., 38, 3228-3231.
90. Wu X, Pang ST, Sahlin L, Blanck A, Norstedt G and Flores-Morales A. (2003). Biol. Reprod., 69, 1308-1317.
91. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T and Kuroiwa Y. (1999). Life Sci., 64, 249-258.
92. Yordy JS, Li R, Sementchenko VI, Pei H, Muise-Helmericks RC and Watson DK. (2004). Oncogene, 23, 6654-6665.